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Abstract: A primary goal in modern surface modification technology of dental implants is to achieve
biocompatible surfaces with rapid but controlled healing which also allow health and longevity of
implants. In order to realize all, understanding of osseointegration phenomena is crucial. Although
Ti-SLA, Ti-SLActive and TiZr-SLActive surfaces have been successfully used in clinical implantology
and were shown to notably reduce the primary healing time, available in vitro studies are sparse
and do not concern or explore the mechanism(s) involved in human osteoblast behavior on these
surfaces. Ti-SLA, Ti-SLActive, TiZr-SLActive, Ti cp, Ticer and Cercon surfaces were used. Osteoblast
proliferation, cell cluster formation, morphological changes, induction of autophagy, nitric oxide
(NO), reactive oxygen species/reactive nitrogen species (ROS/RNS) formation, osteocalcin (OC),
bone sialoprotein (BSP) and collagen type I (Col-1) affected by various surfaces were analyzed. These
surfaces induced formation of mature osteoblasts caused by elevated oxidative stress (ROS) followed
by overexpression of osteoblast maturation key molecule (NO), with different intensity however.
These mature osteoblasts induced upregulation of OC, BSP and Col-1, activating PI3/Akt signalling
pathway resulting in autophagy, known as an important process in differentiation of osteoblast
cells. Additional distinctive subpopulation identified on Ticer, Ti-SLA (after 5 days), Ti-SLActive and
TiZr-SLActive surfaces (after 2 days) were forming cell clusters, essential for bone noduli formation
and mineralisation. The results suggest that Ti- and TiZr-SLActive possess advanced properties in
comparison with Ticer and Ti-SLA manifested as accelerated osteoblast differentiation. These effects
could explain already known fast osseointegration of these surfaces in vivo.
Keywords: implant surfaces; osteoblast; Ticer; SLA; autophagy
1. Introduction
The development of novel dental implant materials as well as elucidation of cellular and
acellular healing mechanisms between implant surface and surrounding solid and soft tissues
have been in progress for over six decades, i.e., from Brånemark’s discovery demonstrating that
titanium could become permanently incorporated into bone [1,2]. In terms of biocompatibility and
osseointegration, Ti cp (commercially pure titanium) represents the golden standard in implant
dentistry [3]. Since it has been shown that physicochemical properties (chemical composition, surface
roughness, micro/nanotopography, wettability, surface charges, etc.) have the most important
influence on cell adhesion, proliferation, differentiation and bone matrix deposition [4,5], major
improvements in material surface development have been achieved in order to reduce the critical
confronts of the implant dentistry. Employing different techniques in preparation of implant surfaces
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(such as machining, acid etching, anodization, plasma spraying, grit blasting or combination methods)
contributed to materials with improved integration processes [6–8]. Many years of research resulted in
several improved materials with advanced mechanical properties, as well as enhanced biocompatibility
and osseointegration [9,10].
Nevertheless, as osseointegration and longevity of implants have been enhanced and prolonged,
clinical indications for implantation expanded as well. Thus, implants were also introduced to patients
with very challenging indications, e.g., in irradiated jaws or poor bone quality. Furthermore, since it
was shown that implant size at macro level can be reduced by increasing the surface area at micro level,
short implants and implants with reduced diameter have been introduced. Consequently, expectations
of the patients were also increased. Obviously, not only successful functional and excellent esthetic
solutions were awaited, but also short and predictable healing time enabling fast loading of implants.
In accordance with the abovementioned, the use of titanium dental implants in clinical practice
increased dramatically. Ticer (ZL Microdent, Breckefeld, Germany), a dental implant with an anodically
oxidized surface, introduced in the 1980s [11] represents a widely used and the first among similar
materials employed in clinical practice. It was found to promote fast osteoblast cell differentiation
and mineralization processes [12,13]. Ti-SLA (Institut Straumann AG, Basel, Switzerland) represents
the surface obtained by combining sandblasting and acid-etching of titanium implant surfaces which
enhance bone integration and long-term stability [3]. Rinsing the Ti-SLA surfaces under nitrogen and
storing in a saline solution yielded Ti-SLActive surface (Institut Straumann AG, Basel, Switzerland)
with improved initial wetting conditions that acted lowering contaminations and its surface was
more active than that of Ti-SLA, expressing beneficial effects on cell differentiation and growth factor
production [3,14–16]. Introducing the Ti-SLActive surfaces in the implantology enabled reduction of
primary healing time (from 6 months to 6 weeks) and more rapid loading of implants [15,17].
Furthermore, in order to solve the esthetic issues of dark-grayish color of titanium implants in
some cases visible through gingiva, Cercon (yttrium tetragonal zirconia-based material; DeguDent,
Rodenbacher, Hanu, Germany) have been created and used in the esthetic zone, as well as in stress
bearing regions [18]. Research related to dental implant surfaces also pointed to the combination of
zirconia and titanium [19,20], e.g., implant body of zirconia and a surface coating of titanium oxide or
vice versa [21–24]. The first attempts did not solve difficulties related to the mechanical stability of
zirconia and potential toxicity of titanium ions, while surfaces with an implant body of titanium and
a surface coating of zirconia expressed beneficial in vitro effects on osteoblast cells similar to Ticer, but
the color problems remained.
With the aim of improving mechanical stability of the implants, enabling usage of shorter implants
and implants with reduced diameter in the atrophic bones, titanium-based alloys were introduced. Due
to their exceptional mechanical strength, corrosion resistance and very satisfactory biocompatibility,
their application is continually increasing [25–27]. Ti6Al4V and TiZr are the most interesting alloys [3,28].
It is well documented that implant diameter represents one of the most important parameters which
exhibit great impacts on the implant fracture [29]. Titanium implants with diameters below 4 mm in the
masticator zone demonstrate low fracture resistance and therefore they cannot be used for that purpose.
Since alloys possess unique mechanical strength, they can be employed to prepare implants with
reduced diameter [30,31]. The application of these implants enables to avoid complicated augmentation
techniques and treatment of tight spaces upon teeth extraction. In 2009, Bernhard et al. developed
binary titanium-zirconium alloy Roxolid (TiZr; ca. 15% Zr; Institut Straumann AG, Basel, Switzerland)
with SLActive surfaces which expressed improved osseointegration [32]. Introducing TiZr-alloys in
implant dentistry allowed application of implants with reduced diameter (e.g., Straumann: 3.3 mm for
incisors and premolar; 2.9 mm for the lower incisors and upper lateral incisors).
To the best of our knowledge, there is no dental implant material which solves either all clinical
problems, or patients’ satisfaction. Even though numerous preclinical and clinical investigations
were performed so far, the process of osseointegration has still not been completely identified at the
cellular level on the material–bone interface. Implants with rough surfaces have been recognized
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as materials that do not promote osteoblast proliferation (a sign of a more differentiated cellular
phenotype in culture) [33–35], but they are able to enhance their maturation and consequently
differentiation process [36–38]. Few reports indicated that this incident might be affected by cytokines,
mitogen-activated protein kinase (MAPK), integrin signalling pathway or by bone morphogenetic
protein-2 [39–41]. Hocking et al. indicated that autophagy plays a role during osteoblast differentiation,
mineralisation and bone homeostasis, but it is not yet clear whether inhibition or activation of
autophagy promotes bone formation [42]. It is well documented that autophagy plays an essential role
in embryogenesis, maintenance of tissue homeostasis, elimination of damaged subcellular structures,
but also could be a mode of physiological cell death [43,44]. On the other hand, autophagy might be
associated with cell differentiation process [45–47].
Recently, we reported a pioneering work on the role of autophagy in the osteoblast differentiation
process [12]. It has been found that rough topographies of titanium-based materials obtained by
anodic oxidation under spark discharge (Ticer and 3 analogue white surfaces) and acid etched (SS)
induced osteoblast differentiation via autophagic PI3/Akt dependent signalling pathway. There are
very sparse in vitro studies with Ti-SLA, Ti-SLActive and TiZr-SLActive surfaces. However, the results
of clinical practice demonstrated that Ti-SLActive and TiZr-SLActive surfaces facilitated reduction
of primary healing time decreasing it from six months to six weeks and provided a rapid loading of
implants [15,17]. All these data encouraged us to explore whether this phenomenon could be explained
by the results of some in vitro studies. In addition, the effects of TiZr-alloy (SLActive surface) on
osteoblast response were examined and compared with those obtained using Ti-based materials. Thus,
the aim of the present study was to evaluate surface topography effects of several surfaces widely and
successfully employed in clinical practice such as Ti-SLA, Ti-SLActive and TiZr-SLActive surfaces on
osteoblast proliferation and morphology and on expression of bone sialoprotein (BSP), osteocalcin
(OC), collagen type I (Col-1) and endogenous nitric oxide (NO). The role of autophagy in osteoblast
differentiation on these materials was also explored.
2. Materials and Methods
2.1. Materials
The reference material Ticer and Ti cp, as well as Ti-SLA, Ti-SLActive, TiZr-SLActive and
Cercon were kindly obtained from ZL Microdent, Germany and Institut Straumann AG, Basel,
Switzerland, respectively.
2.2. Cell Isolation and Culture
All procedures employed in this study were approved by the Ethics Committee of the University
of Leipzig (No. 086-2008) and performed according to the rules of the Declaration of Helsinki
from 1975 (revised in 1983). Human mandibular bone samples without any clinical or radiographic
pathological evidence were obtained from three male donors undergoing lower wisdom tooth surgery
at the Department of Oral, Maxillary, Facial and Reconstructive Plastic Surgery at the University
Hospital of Leipzig. The bone samples and cell isolation were performed as described previously [48].
Afterwards, the cells were subcultured from initially isolated primary cells and seeded in chamber
slides (Nunc™ Lab-Tek™ II Chamber Slide™ System, Thermo Scientific™ Nalgene™; Darmstadt,
Germany; 2000 cells/well) or 96-well plates (20,000 cells/well) containing Ti cp, Cercon, Ticer, Ti-SLA,
Ti-SLActive and TiZr-SLActive. All experiments were performed in triplicate.
2.3. DAPI Staining of the Cells
Cells attached to the investigated materials from the eight chamber slides were rinsed several
times with PBS. Then, the cell nuclei were stained with 4,6-diamidino-2-phenylindole dihydrochloride
(DAPI; Serva, Heidelberg, Germany) and cell proliferation was determined as the number of cells on
the investigated surfaces [49].
Coatings 2017, 7, 102 4 of 18
2.4. Acridin Orange Staining—Microscopy
The cells were allowed to grow on different materials for 2, 5, 7 and 10 days and stained with
acridine orange (AO, 15 µL, 3 µg/mL). A motorized Zeiss Axiophot2 microscope (Zeiss, Oberkochen,
Germany) equipped with the appropriate filter (Semrock Inc., Rochester, NY, USA, FF01-500/LP-25
500 nm blocking edge BrightLine® (Huntingdon, UK) long-pass filter transmission band 1519–700 nm)
was used for analyses. The cell morphology was determined as previously described [48]. In short, cell
morphology was evaluated by measuring the footprint area of the cell on the surface after attachment
and using a shape factor, φ = (4piA)/p2 (A = footprint area; p = the perimeter of the cell).
2.5. BSP, OC and Col-1 Expression
Eight chamber slides with the osteoblast cells were removed from the incubator after 2, 5, 7
or 10 days and the cells were fixed in paraformaldehyde (4% PFA in PBS) for 15 min and rinsed
in PBS. The attached cells were treated for 2 h with 10% normal goat serum (Vector, Burlingame,
CA, USA) in PBS and incubated overnight at 4 ◦C with 1:100 diluted primary antibody against
BSP (monoclonal, mouse-anti-human; Immundiagnostik AG, Bensheim, Germany) or osteocalcin
(monoclonal, mouse-anti-human; Acris, Hiddenhausen, Germany) or Col-1 (Acris Antibodies GmbH,
Herford, Germany). After washing in PBS, the bound primary antibodies were visualized by incubation
for 2 h with 1:50 (BSP, OC) or 1:200 (Col-1) diluted goat-antirabbit-Cy3 (Jackson Immuno Research,
West Grove, PA, USA) in PBS containing 2% bovine serum albumin (Serva). After rinsing several times
in PBS, cell preparations were counterstained using DAPI (Serva) and coverslipped. Zeiss Axiophot2
microscope equipped with the appropriate filters (DAPI: Zeiss, Filter Set 01 (488001-9901-000) excitation
365/12 nm emission 397 nm; Cy3: Zeiss, Filter Set 43 HE (489043-9901-000) excitation 550/25 nm
emission 605/70 nm) were used for visualization.
2.6. Acridin Orange Staining—Flow Cytometry
For flow cytometric analyses after 24 and 48 h, cells were trypsinized, collected and conducted
to further evaluation. Detached cells were stained with 1 µM AO for 15 min at 37 ◦C. At the end of
incubation period, the cells were washed and resuspended in PBS. Cells were analyzed (excitation
488 nm, emission 650 nm) on Partec FloMax® software (version 2.82, Partec GmbH, Münster, Germany).
Compensation was not used. In total, 20,000 events were analyzed.
2.7. NO Production—Flow Cytometry
For intracellular NO detection, cells were trypsinized, washed and incubated for 1 h at 37 ◦C
with 1.5 µM of NO indicator DAF-FM (4-amino-5-methylamino-2′,7′-difluorofluorescein) diacetate
(Molecular Probes) in phenol red and serum-free medium. Then the cells were washed in PBS
and incubated for additional 15 min at 37 ◦C in phenol red free medium for deesterification of the
intracellular diacetates. Finally, the cells were resuspended in PBS and analyzed (excitation 488 nm,
emission 495/515 nm) by CyFlow® (Partec GmbH, Münster, Germany) Space Partec using the Partec
FloMax® software (Partec GmbH, Münster, Germany).
2.8. Reactive Oxygen Species/Reactive Nitrogen Species (ROS/RNS) Production—Flow Cytometry
The production of ROS/RNS was determined by redox-sensitive dye, dihydrorhodamine 123
(DHR). The cells were stained with 1 µM DHR for 20 min before exposure to materials. After 24 or
48 h of incubation, they were detached, washed with PBS, and the fluorescence intensity was analyzed
with CyFlow® Space Partec using the Partec FloMax® software.
2.9. Statistical Analysis
Data from the repeated experiments are presented as the mean and standard deviation.
The significance of the differences between various treatments was assessed by ANOVA followed
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Several different topographies employed clinically as dental implants were used in this study:
Ti cp, Cercon, Ticer, Ti-SLA, Ti-SLActive and TiZr-SLActive. Ti cp (smooth titanium surface) and Ticer
(rough titanium surface obtained by anodic spark deposition) served as the controls, because they
were investigated in vitro as reported earlier [21,48]. Additionally, smooth topography material based
on zirconia (Cercon) was used for comparison. Although Ti-SLA, Ti-SLActive and TiZr-SLActive
topographies have been investigated in vivo and in clinical practice [50–55], studies on human primary
cells are still limited [56–59]. Osteoblast cells were allowed to proliferate on the investigated implant
surfaces up to 10 days and evaluated by the DAPI assay (Figure 1). After only 2 days of cultivation,
a significantly higher number of the cells was found on Ti cp, Cercon, and Ticer than on Ti-SLA,
Ti-SLActive and TiZr-SLActive. The highest osteoblast proliferation was observed on day 2 of
cultivation on Cercon, followed by Ti cp, and these values significantly differed from those found on
other surfaces. In direct comparison of Ticer, Ti-SLA, Ti-SLActive and TiZr-SLActive surfaces, on days
7 and 10, cell number was significantly increased only on Ti cp and Cercon. Moreover, proliferation
was significantly lower on Ti-SLActive and TiZr-SLActive than on Ticer or Ti-SLA.
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Figure 1. Proliferation of osteoblasts on various clinically employed surfaces (* p < 0.05 vs. Ti cp, 
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3.2. Cell Morphology 
The influence of the investigated materials on the osteoblast morphology was explored for up 
to 10 days of incubation (Figure 2). During the investigated time, osteoblasts grown on the Ti cp and 
Cercon were exclusively fully spread and exhibited flattened morphology, lying parallel to each 
other, indicating no influence of the smooth topographies under experimental conditions applied. 
Contrary to that, the cells did not lie parallel to each other on rough surfaces, but appeared as building 
groups—cell clusters with changed morphology. Explicitly, in accordance with previously reported 
results [48], on Ticer and Ti-SLA surfaces, osteoblast morphology changed to polygonally shaped 
cells from day 2 to 10 (some 20% to 70% of the cell population). Interestingly, on day 2 of the 
experiment, only 65% and 55% of the cells on Ti-SLActive and TiZr-SLActive, respectively, were 
flattened, while from day 5 on, only polygonal cells were recorded on these two surfaces, however 
there were two different types of polygonal cells. 
i re 1. r liferati f ste lasts ari s cli icall e l e s rfaces (* p 0.05 s. i c ,
rc , icer, Ti-SLA; # p < . s. rc ; ** . s. i c , rc ).
3.2. Cell Morphology
The influence of the investigated materials on the osteoblast morphology was explored for up
to 10 days of incubation (Figure 2). During the investigated time, osteoblasts grown on the Ti cp
and Cercon were exclusively fully spread and exhibited flattened morphology, lying parallel to each
other, indicating no influence of the smooth topographies under experimental conditions applied.
Contrary to that, the cells did not lie parallel to each other on rough surfaces, but appeared as building
groups cell clusters with changed morphology. Explicitly, in accordance with previously reported
results [48], on Ticer and Ti-SLA surfaces, osteoblast morphology changed to polygonally shaped cells
from day 2 to 10 (some 20% to 70% of the cell population). Interestingly, on day 2 of the experiment,
only 65% and 55% of the cells on Ti-SLActive and TiZr-SLActive, respectively, were flattened, while
from day 5 on, only polygonal cells were recorded on these two surfaces, however there were two
different types of polygonal cells.
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3.3. Cell Cluster Formation
Clust ring of the cells was investigated after 48 h of osteoblast cultivation on t e inv stigated
surfaces. The cells were homogenously spread on the Ti cp, Cercon, Ticer and Ti-SLA, while already
being organized in clusters on Ti-SLActive and TiZr-SLActive. After 96 h of culture, cell clusters were
also observed on Ticer and Ti-SLA surfaces (Figure 3).
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3.4. Osteocalcin, Bone Sialoprotein and Collagen Type I
Immunocytochemistry was applied to detect and quantify OC, BSP and Col-1 production in
osteoblasts incubated on different surfaces. During the differentiation phase, osteoblasts deposit
protein matrix on the surfaces. This is characterized by upregulation of OC, BSP and Col-1 (Figure 4).
Similar expressions of OC, BSP, and Col-1 were detected in osteoblasts on Ti cp, Cercon, Ticer and
Ti-SLA on day 2 of culture, while osteoblasts grown on Ti-SLActive and TiZr-SLActive surfaces already
expressed a significantly higher production rate of the mentioned molecules. The highest production
of all examined species was recorded on day 5 of culture on Ti-SLActive and TiZr-SLActive, while the
peak production on Ticer and Ti-SLA was detected on day 10 of the experiment.
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Figure 4. Time dependent production of osteocalcin (OC), bone sialoprotein (BSP) and collagen type I
(Col-1) on various surfaces (* p < 0.05 vs. Ti cp, Cercon, Ticer, Ti-SLA; # p < 0.05 vs. Ti cp, Cercon).
3.5. Production of NO and ROS/RNS in Large Granular Cells
DAF-FM diacetate and DHR stainings were employed for detection of NO and ROS/RNS [60–63].
Osteoblasts were cultivated on six surfaces of different topographies and intracellular levels of NO and
ROS/RNS were examined. Only large granular cells (FSC high/SSC high) produced both enhanced
intracellular NO and ROS/RNS levels (Figure 5). On the other hand, low granular small cells (FSC
low/SSC low) showed no enrichment either in NO or in ROS/RNS amount. The production of both
NO and ROS/RNS depended on the specificity of the surface itself. A high amount f NO in large
Coatings 2017, 7, 102 8 of 18
granular cells was observed in cultures grown on Ti-SLActive and TiZr-SLActive to be followed by Ticer
and Ti-SLA. Ti cp and Cercon triggered the lowest NO production in comparison with other surfaces
examined here. Similar to NO detection results, the level of ROS/RNS species was also significantly
higher in large granular cells than in small granular ones (Figure 5b). However, a higher amount of
ROS/RNS was observed in the cells incubated on Ticer, Ti-SLA, Ti-SLActive and TiZr-SLActive in
comparison with Ti cp and Cercon.
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Figure 5. (a) NO and (b) ROS/RNS expression of cells grown on different surfaces (DAF-FM diacetate
and DHR staining, respectively):  low granular small cells (FSC low/SSC low);  large granular cells
(FSC high/SSC high).
3.6. Autophagy Induction
To find out whether autophagy is involved in the observed morphological changes and cell
cluster formation, the cells were cultivated for 24 and 48 h in the presence of six different surfaces and
AO staining was subsequently performed. AO is staining the autophagosomes, the hallmark of the
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autophagy process, exhibiting green to red fluorescence, depending on medium acidity [64,65]. Cell
size and granularity were determined by flow cytometric analysis [66,67]. After only 24 h of osteoblast
growth on the surfaces used here, small cells of low granularity and without autophagy were the most
abundant population (FSC low/SSC low; Figure 6a). On the other hand, intensified autophagy was
observed in larger cells with high granularity (FSC high/SSC high; Figure 6b). At least three times
more of such cells were recorded on Ti-SLActive and TiZr-SLActive topographies (FSC high/SSC high;
Figure 6a) than on other surfaces. After 48 h of culture, a discrete subpopulation of smaller, granular
cells exhibiting less autophagy than the cells from the other subpopulation, were observed only on
Ti-SLActive and TiZr-SLActive surfaces (Figure 7).
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Figure 6. Presence of autophagosomes in a discrete population of osteoblasts cultivated (24 h) on the
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4. Discussion
Recently, it was elucidated that autophagy plays an important role in osteoblast differentiation
when cultivated on anodical titanium-based topographies [12]. In addition to three white novel
titanium-based surfaces, Ticer, a clinically used surface, was employed in the previously reported
stu y. I order to find out whether chemical composition of dental implant surfaces affects
osteoblast differentiation, Ti-SLA, Ti-SLActive and TiZr-SLActive (all rough; Ra = 1.5, 1.6 and 1.6 µm,
resp ctiv ly) [68,69] materials, as well as Cercon (smooth; Ra < 0.2 µm), zirconia material, were selected
for the present study. Ti cp (smooth; Ra < 0. µm) and Ticer (rough; Ra = 1.4 µm) [22] titanium-based
surfaces (inves igated previously) [12], served as controls. The results of this work will confirm and
exte d the hypothesis that surface t pography, as well as the composition of dental impl ts influence
not only cell proliferation, but also morphology and expression of BSP, OC and Col-1 of osteoblasts.
As observed previously, cell proliferation was increasing during the investigated time period only
on Ti cp and Cercon surfaces [21,48]. However, a similar cell proliferation rate was recorded on Ti cp,
Cercon, Ticer and Ti-SLA on day 2 of incubation. From day 5 of culture on Ticer and Ti-SLA, number
of the cells was significantly lower compared to those observed on two smooth surfaces (Ti cp and
Cercon). Interestingly, a significantly lower number of the cells was noticed in all investigated time
points on Ti-SLActive and TiZr-SLActive surfaces.
Osteoblast proliferation was found to be influenced by surface roughness (Figure 1) [70], while
chemical composition of the surface seems to express additional effects. The results of the present
study are in accordance with earlier findings demonstrating that acid etched (e.g., Ti-SLA) as
well as anodically oxidized surfaces (e.g., Ticer) resulted in low cell proliferation rate. However,
clinical practice showed that dental implants with such surfaces exhibit fast osseointegration and
improved bone to implant contact [71,72]. It is obvious that smooth Ti cp and Cercon surfaces
induced proliferation of the cells. Materials pr moting cell proliferation are mainly unsuitable for
cell differentiation [73,74]. However, our results showed th t the number of osteoblasts remained
almost onstant from day 5 of cultivation on rough surfaces such as Ticer, Ti-SLA, Ti-SLActive
and TiZr-SLActive.
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Discrepancies in cell proliferation rate on materials of various topographies were evident already
from day 2 of incubation. Interestingly, such cell behavior was also accompanied with morphology
changes and affected biochemical parameters of the examined protein expressions. As expected,
smooth surfaces such as Ti cp and Cercon caused no alteration in osteoblast morphology up to day 10
of experiments. However, Ti-SLActive and TiZr-SLActive surfaces highly affected cell morphology
and already on day 2 of cultivation at least 35% cells exhibited polygonal morphology, while from
day 5 on, only polygonal cells were identified. This effect was not so prominent in the cells cultivated
on Ticer and Ti-SLA. Thus, on day 3 of culture, only 20% and on day 10 at least 70% of cells were
polygonally shaped. Cell shape represents one of the most important regulators of proliferation
rate and differentiation and division of polygonally shaped cells proceeds by a much lower rate in
relation to that of well spread flattened cells [21]. Polygonally (rounded) configured osteoblasts point
toward a high synthetic activity of the cells. Influence of the fast morphological changes (flattened→
polygonal) is considered to be a positive influence of material.
The observed cell response differences related to the investigated surface topographies could
be connected to cell morphology alterations (activation of signaling pathways, gene expression,
differentiation, cell shape, motility, etc). Furthermore, changes in the extracellular matrix trigger
the pathways that affect growth and phenotype differentiation [75]. The cells cultivated on various
materials examined here showed an enhanced production of OC, BSP and Col-1 with the exception
of Ti cp and Cercon. It seems that Ti-SLActive and TiZr-SLActive surfaces stimulate expression of
several biochemical markers of osteoblast differentiation much faster than Ticer or Ti-SLA. Osteoblast
differentiation is accompanied by upregulation of OC, BSP and Col-1 [76–78]. As one of the most
specific markers of mature osteoblasts [76,77], OC plays an important role in the bone matrix formation.
Enhanced BSP levels are present in early stages of bone maturation [48,79]. Moreover, BSP acts as
a nucleator for mineralization in bone [80]. Cell growth on collagen gels acts by inducing rapid
differentiation of osteoblastic cells [75]. Thus, the enhancement of Col-1 formation in the extracellular
matrix could be interpreted as an indicator of the osteoblast differentiation process reported here.
This is in accordance with the abovementioned results showing that Ticer, Ti-SLA, Ti-SLActive and
TiZr-SLActive act by promoting osteoblast differentiation expressed as irregular and polygonal cellular
morphology and increased levels of key proteins related to the osteogenic phenotype [81].
In addition to significant material topography-related differences observed here not only in
proliferation rate but also in morphological appearance and protein expression of osteoblast cells,
discrepancies in cell cluster formation were detected as well. As previously shown using Ti cp [12],
cell cluster formation was not observed throughout the present study when smooth surface materials
such as Cercon and Ti cp were applied. Also, no variation in cell size in either morphology was
observed. Thus, cells exhibited flattened morphology, were well spread and laid parallel to each
other indicating good attachment. Contrary to that, on Ti-SLActive and TiZr-SLActive surfaces on
day 2, migrations of cells and cell clustering were observed. Those clusters were exclusively formed
from the small polygonal cells, highly differentiated ones, presenting the next step in the process of
osteoblast maturation, as reported previously [12]. On Ticer and Ti-SLA, cell clusters were formed on
day 5 of culture. Cell clusters are essential for osseointegration because they are precursors of bone
noduli formation [12]. Lundberg et al. showed that bone-relevant biological molecules (e.g., vasoactive
intestinal peptide) hinder mouse calvariae osteoblast proliferation and enhance differentiation rates of
committed noduli-forming cells [82]. Moreover, it was reported that autophagy exhibits a crucial effect
on osteoblast function related to its role in supporting osteoblast noduli formation [83]. In order to
investigate whether autophagy is connected to cell cluster formation, 3MA, an autophagy inhibitor,
was added to the osteoblasts cultured on surfaces differing in topography. Our results showed that
3MA prevented cluster formation of osteoblast cells (data not shown). This is consistent with our
recently reported results [12]. It was also shown that treatment with autophagy inhibitors in vivo led
to defective osteoblast noduli formation [83].
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Flow cytometric analysis of autophagy after 24 h of osteoblast cultures revealed the presence of
two discrete cell subpopulations. The first subpopulation consisted of cells with low granularity and
low autophagy, namely osteoblasts. The second subpopulation included remarkably larger, highly
granulated cells with intensified autophagic processes, i.e., mature osteoblasts were observed. After
48 h of culture, the third cell subpopulation was identified only when Ti-SLActive and TiZr-SLActive
surfaces were used. Morphologically, these cells can be classified as smaller and granular cells.
Nevertheless, these cells showed lower autophagy levels in relation to the second cell subpopulation.
Using fluorescence microscopy, small and polygonal cells were also detected on Ti-SLActive and
TiZr-SLActive as early as day 2 of culture. This could be the same type of cell (third subpopulation)
identified with flow cytometry. In the process of osteoblast maturation, this subpopulation represents
the next step. As reported earlier [12], osteoblasts have to grow for at least 72 h on Ticer to visualise
the third cell subpopulation. Consequently, depending on the topography and composition of the
surface, distinctive kinetics of this process take place within the cells.
Increased OC production recorded in cells cultivated on Ti-SLActive and TiZr-SLActive, apart
from Ticer and Ti-SLA, could be connected to the activation of PI3/Akt signalling pathway, which is
responsible not only for autophagy activation but also for osteoblast differentiation [42]. Pantovic et al.
showed that human dental pulp mesenchymal stem cells differentiate via AMPK-induced autophagy
and Akt activity to osteoblasts [84].
Production of NO as one of the osteoblast differentiation and maturation hallmarks was
determined by flow cytometry. Flow cytometric analysis after only 24 h of cell culture on the
investigated surfaces revealed a cell subpopulation producing enhanced NO levels. This subpopulation,
consisting of large cells with high granularity, coincides with high autophagy cell subpopulations. The
first subpopulation containing immature osteoblasts exhibited low NO production and a constant
autophagy level.
NO plays an important role in bone homeostasis [85,86]. Inhibition of NO production in
mice was shown to cause severe abnormalities in bone formation because of delaying osteoblast
differentiation [87]. Some of the research pointed to a key role of NO in both intra- and intercellular
response to mechanic stimuli [88]. As mentioned above, the second cell subpopulation containing
remarkably larger cells of higher granularity had significantly increased NO levels in comparison
with that found in small size cell subpopulations. It is obvious that mechanical stimulation of cell
membrane by material surface promoted intracellular response mediated at least partly by enhanced
NO production. This molecule is known as a modulator of numerous signalling pathways including
transcriptional pathways (e.g., YY1, SP11 . . . ), thus regulating proteins and genes involved in cell
proliferation, differentiation and cell death [89].
To address the question on whether stress could act as an autophagy trigger, the presence of
ROS/RNS in osteoblasts grown on different surfaces was evaluated. Similar to investigations related
to NO, a high quantity of ROS/RNS was identified in the second cell subpopulation. Mechanical stress
might cause induction of autophagy [90,91]. All our results presented here contribute to the suggestion
that the employed materials mechanically stimulated osteoblast maturation followed by amplified
production of ROS/RNS and intracellular NO. Surface topography could be sufficiently effective in
directly or indirectly causing cell stress and thus influencing osteoblasts differentiation [92]. Both
NO and ROS/RNS might damage organelles leading to cell death. Moreover, ROS could be fatal for
osteoblasts as a main factor causing cell death and several bone diseases. On the other hand, NO plays
an important role as a mediator of cellular differentiation (osteoblast, osteoclast and other cells) [93].
However, in the case of the investigated surfaces, it seems that both ROS and NO species present in
suitable concentrations could act by modulating key signalling pathways.
Ti-alloys have been introduced in implantology in order to improve mechanical stability.
Nevertheless, biological response of these alloys has been questioned. Data presented in this study
confirmed the observation from clinical practice related to efficacy of Ti-SLActive and TiZr-SLActive
implant surfaces and their ability to promote fast osteoblast differentiation. Abundance of large cells
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with high granularity (FSC high/SSC high) in parallel with enhanced autophagy, high intracellular NO
and ROS/RNS production in cells exposed to Ti-SLActive and TiZrSLActive indicated that composition
of these materials and their surface topographies despite the chemical differences (Ti vs. TiZr-alloy,
respectively) are crucial for their improved biological compatibility.
5. Conclusions
Findings reported herein contribute to the superiority of rough over smooth dental implant
surfaces (Ti cp, Cercon) in the sense of interaction with osteoblasts. Moreover, it was shown that
hydrophilic Ti-SLActive and TiZr-SLActive topographies possess advanced properties, in comparison
with Ti cp, Cercon, Ticer and Ti-SLA, reflected in accelerated osteoblast differentiation. However,
analogously to Ticer, Ti-SLActive and TiZr-SLActive surfaces induced a stress, reflected through ROS
production, subsequently followed by NO formation. High levels of ROS/RNS and NO were only
present in mature osteoblasts (highly granular, polygonally shaped cells). This cell subpopulation
produced enhanced levels of OC, BSP and Col-1 and exhibited high autophagy. Taking all these results
into account, it can be concluded that a faster autophagic process (24 h) triggered by contacts between
the cells and Ti- or TiZr-based rough surfaces generates osteoblast maturation and differentiation with
the involvement of PI3/Akt signalling pathway. Moreover, there is a debatable question on whether Ti
or TiZr-alloy is superior as dental implant material [3,94]. Based on our results presented here, it can be
claimed that, at least under in vitro conditions, both Ti-SLActive and TiZr-SLActive implant surfaces
expressed a similar tendency of promoting fast osteoblast differentiation.
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